claim
The discovery of a protein closely involved with EGFR-KRAS signaling offers a potential method to thwart resistance pathways against RAS-targeted drugs in pancreatic cancer and other KRAS-associated tumors.
Authors
Sources
- The breakthroughs behind UT MD Anderson's quest to end cancer www.nature.com via serper
Referenced by nodes (1)
- pancreatic cancer concept